Improvement of exercise capacity of rats with chronic heart failure by long‐term treatment with trandolapril
Open Access
- 1 April 1999
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 126 (7) , 1585-1592
- https://doi.org/10.1038/sj.bjp.0702471
Abstract
1. The effects of long-term treatment with trandolapril, an angiotensin I-converting enzyme inhibitor, on exercise capacity of rats with chronic heart failure (CHF) following coronary artery ligation were examined. CHF was developed by 8 weeks after the coronary artery ligation. 2. The running time of rats with CHF in the treadmill test was shortened to approximately 65% of that of sham-operated rats (16.3+/-1.2 vs. 25.1+/-1.6 min, n = 7; P<0.05). ATP, creatine phosphate (CP), and lactate contents of the gracilis muscle of rats with CHF were similar to those of sham-operated rats before running. After running, ATP and CP were decreased and lactate was increased in both rats with CHF and sham-operated rats. There were no significant differences in the levels of energy metabolites between rats with CHF and sham-operated rats. The rates of decrease in ATP and CP and rate of increase in lactate in the gracilis muscle of rats with CHF during exercise were greater than those of sham operated rats (2.5, 2.0 and 1.5 fold high, respectively), suggesting wastage of energy during exercise in the animals with CHF. 3. Myofibrillar Ca2+ -stimulated ATPase (Ca-ATPase) activity of skeletal muscle of rats with CHF was increased over that of the sham-operated control (62.03+/-1.88 vs. 52.34+/-1.19 micromol Pi mg(-1) protein h(-1) n = 7; P<0.05). The compositions of myosin heavy chain (MHC) isoforms of gracilis muscle were altered by CHF; decreases in MHC types I and IIb and an increase in MHC type IIa were found (P<0.05). 4. Rats with CHF were treated with 1 mg kg(-1) day(-1) trandolapril from the 2nd to 8th week after surgery. Treatment with trandolapril prolonged the running time, reversed the rates of decrease in ATP and CP and the rate of increase in lactate, and restored the Ca-ATPase activity (51.11+/-0.56 micromol Pi mg(-1) protein h(-1), n = 7; P<0.05) and composition ratio of MHC isoforms in the gracilis muscle. 5. The results suggest that long-term trandolapril treatment of rats with CHF may restore their ability to utilize energy without wastage and thus improve exercise capacity.Keywords
This publication has 35 references indexed in Scilit:
- The “Muscle Hypothesis” of Chronic Heart FailureJournal of Molecular and Cellular Cardiology, 1996
- Skeletal Muscle Metabolism in Experimental Heart FailureJournal of Molecular and Cellular Cardiology, 1996
- A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1995
- Effects of Trandolapril on Cardiac Angiotensin I Converting Enzyme Activity in Rats with Chronic Heart Failure Following Myocardial Infarction.Japanese Heart Journal, 1995
- Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.Heart, 1994
- Pulmonary hypertension and systemic hypotension as limitations to exercise in chronic heart failurePublished by Elsevier ,1994
- Symptoms and quality of life in heart failure: the muscle hypothesisHeart, 1994
- Regional Energy Metabolism of Failing Hearts Following Myocardial InfarctionJournal of Molecular and Cellular Cardiology, 1993
- Early treatment with captopril after acute myocardial infarction.Heart, 1993
- The purification of cardiac myofibrils with Triton X-100Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1971